Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function

Cansev M.

Central Nervous System Agents in Medicinal Chemistry, vol.7, no.4, pp.223-229, 2007 (Scopus) identifier


The uridine nucleotides UTP, UDP and UDP-sugars produce a variety of effects by activating specific G protein-coupled P2Y receptors, i.e., the P2Y2, P2Y4, P2Y6 and P2Y14 variants. Except for P2Y14 which has recently been defined, stimulation of P2Y receptors by UTP and/or UDP augments proliferation of adult multipotent neural stem cells; stimulates dopaminergic differentiation in human mesencephalic neural stem cells; and enhances neurite outgrowth in nerve growth factor-differentiated PC12 cells and cultured DRG neurons. UTP and/or UDP have been shown to affect neuronal function by depolarizing neurons from cultured amphibian sympathetic ganglia; increasing firing rates of neurons; enhancing presynaptic glutamate release and promoting long-term potentiation; and by stimulating noradrenaline release from cultured sympathetic neurons. Furthermore, by activating P2Y receptors, UTP and/or UDP exhibit neuroprotective effects via induction of microglial convergence and reactive astrogliosis; protection from serum starvation-induced apoptosis; and stimulation of α-secretase-dependent APP processing and sAPPα release. Antagonism of uridine- nucleotide-stimulated P2Y receptors or the second messengers they generate, or degradation of extracellular uridine nucleotides, can block the effects mediated by these receptors. These observations suggest that uridine-nucleotide-stimulated P2Y receptors may constitute possible therapeutic targets for diseases affecting neuronal survival or function. © 2007 Bentham Science Publishers Ltd.